Clinical Trial

Norwegian Distal Ulna Resection - Replacement Study

Study acronym: NORDURR
Recruiting
View on ClinicalTrials.gov →
Summary
Osteoarthritis of the joint between the forearm bones at the wrist (distal radioulnar joint, DRUJ) is a common sequel of fracture and ligament injuries or degenerative disease of the wrist. Intact DRUJ is important for normal load transfer from the hand to the forearm. DRUJ osteoarthritis leads to pain and decreased lifting capacity and rotation of the forearm. The standard treatment is resection of the ulnar head, known as the Darrach procedure. After the resection there is no longer contact in the affected joint, however, some patients can experience instability or impingement between the forearm bones. With ulnar head implant replacement may the load transfer and the stability between the forearm bones less affected. Studies with good long term results are published with both resection and replacement. However, these methods were never compared and thus it is not clear, which of the methods gives the best clinical result and less complications. The aim of this study is to compare Darrach procedure with ulnar head replacement in a prospective randomized multicenter study. Several hand surgical centers form Norway would participate this study. Individuals seeking treatment for their stable but painful DRUJ joints will be included and randomized to either Darrach procedure or ulnar head implant. Participants will be followed up to 5 years. Range of motion and grip strength measures and functional scores would be registered before operation, after 3 months, 1 and 5 years. Eventual complications and reoperations would be also registered.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-08-28; most recent amendment 2024-04-05.
Status change: Not Yet Recruiting → Recruiting 2021-03-03
Trial Details
NCT Number NCT04074863
Lead Sponsor Ostfold Hospital Trust
Conditions Osteoarthritis Wrist
Enrollment 40 participants
Start Date 2020-09-16
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-08